Recombinant human epidermal growth factor enhances wound healing of pyoderma gangrenosum in a patient with ulcerative colitis

Inflamm Bowel Dis. 2008 May;14(5):725-7. doi: 10.1002/ibd.20327.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Topical
  • Adult
  • Colitis, Ulcerative / complications*
  • Epidermal Growth Factor / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Pyoderma Gangrenosum / complications
  • Pyoderma Gangrenosum / drug therapy*
  • Pyoderma Gangrenosum / pathology
  • Recombinant Proteins
  • Wound Healing / drug effects*

Substances

  • Recombinant Proteins
  • Epidermal Growth Factor